CANbridge Life Sciences
Bio-pharmaceutical company accelerating development and commercialization of specialty healthcare.
Employees
Enterprise value
$490m
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | €0.0 | round |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor investor investor investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor investor investor investor investor investor | €0.0 | round | |
| investor investor investor investor investor investor investor investor investor investor investor | €0.0 Valuation: €0.0 | round | |
* | N/A | $77.0m | IPO |
| Total Funding | 000k | ||
YuanMing Capital(exited)
TF Capital(exited)
General Atlantic(exited)
RA Capital Management(exited)
Hudson Bay Capital Management(exited)
Tigermed(exited)
3W Partners(exited)
Casdin Capital(exited)
Summer Capital(exited)
SPDB International(exited)
Yaly Capital(exited)
LYFE Capital(exited)
Qiming Venture Partners(exited)
WuXi AppTec(exited)
Lapam Capital(exited)
3W Partners(exited)
Hangzhou Tigermed(exited)
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.